efavirenz and dpc 961
efavirenz has been researched along with dpc 961 in 8 studies
Research
Studies (8)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (87.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Corbett, JW; Cordova, BC; Erickson-Viitanen, SK; Gearhart, LA; Klabe, RM; Ko, SS; Rodgers, JD | 1 |
| Anderson, PS; Bacheler, LT; Corbett, JW; Cordova, BC; Diamond, S; Erickson-Viitanen, SK; Garber, S; Gearhart, LA; Jeffrey, S; Klabe, RM; Ko, SS; Logue, K; Magnus, NA; Rodgers, JD; Trainor, GL | 1 |
| Corbett, JW; Cordova, BC; Erickson-Viitanen, SK; Garber, S; Klabe, RM; Markwalder, JA; Pan, S; Rodgers, JD | 1 |
| Corbett, JW; Cordova, BC; Erickson-Viitanen, SK; Klabe, RM; Kresge, KJ; Pan, S; Rodgers, JD | 1 |
| Bacheler, LT; Chidester, DR; Cocuzza, AJ; Cordova, BC; Diamond, S; Erickson-Viitanen, SK; Jeffrey, S; Klabe, RM; Ko, SS; Rodgers, JD; Weigelt, CA | 1 |
| Kang, X; Kollman, PA; Kuntz, ID; Wang, J | 1 |
| Bastos, MM; Bezerra, TC; Boechat, N; Costa, CCP; da Silva, FC | 1 |
| Caballero, J; Castro, EA; Duchowicz, PR; Fernández, FM; Fernández, M | 1 |
Reviews
1 review(s) available for efavirenz and dpc 961
| Article | Year |
|---|---|
Efavirenz a nonnucleoside reverse transcriptase inhibitor of first-generation: Approaches based on its medicinal chemistry.
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Chemistry, Pharmaceutical; Cyclopropanes; HIV Reverse Transcriptase; HIV-1; Humans; Molecular Conformation; Reverse Transcriptase Inhibitors; Structure-Activity Relationship | 2016 |
Other Studies
7 other study(ies) available for efavirenz and dpc 961
| Article | Year |
|---|---|
Novel 2,2-dioxide-4,4-disubstituted-1,3-H-2,1,3-benzothiadiazines as non-nucleoside reverse transcriptase inhibitors.
Topics: Benzothiadiazines; HIV-1; Humans; Molecular Structure; Reverse Transcriptase Inhibitors | 2000 |
Inhibition of clinically relevant mutant variants of HIV-1 by quinazolinone non-nucleoside reverse transcriptase inhibitors.
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Blood Proteins; Cyclopropanes; HIV Reverse Transcriptase; HIV-1; Humans; Molecular Structure; Mutation; Oxazines; Protein Binding; Quinazolines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Virus Replication | 2000 |
3,3a-Dihydropyrano[4,3,2-de]quinazolin-2(1H)-ones are potent non-nucleoside reverse transcriptase inhibitors.
Topics: Binding Sites; Combinatorial Chemistry Techniques; Drug Resistance; Heterocyclic Compounds, 2-Ring; Heterocyclic Compounds, 3-Ring; HIV Reverse Transcriptase; Humans; Inhibitory Concentration 50; Models, Molecular; Point Mutation; Pyrans; Quinazolines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship | 2001 |
Trifluoromethyl-containing 3-alkoxymethyl- and 3-aryloxymethyl-2-pyridinones are potent inhibitors of HIV-1 non-nucleoside reverse transcriptase.
Topics: Anti-HIV Agents; Combinatorial Chemistry Techniques; Cytopathogenic Effect, Viral; Enzyme Inhibitors; Fluorine; HIV Reverse Transcriptase; HIV-1; Inhibitory Concentration 50; Mutation; Pyridones; Structure-Activity Relationship | 2001 |
4,1-Benzoxazepinone analogues of efavirenz (Sustiva) as HIV-1 reverse transcriptase inhibitors.
Topics: Alkynes; Animals; Benzoxazines; Cyclopropanes; HIV Reverse Transcriptase; Humans; Macaca mulatta; Oxazines; Protein Binding; Quinazolines; Quinazolinones; Reverse Transcriptase Inhibitors; Structure-Activity Relationship | 2001 |
Hierarchical database screenings for HIV-1 reverse transcriptase using a pharmacophore model, rigid docking, solvation docking, and MM-PB/SA.
Topics: Allosteric Site; Anti-HIV Agents; Crystallography, X-Ray; Databases, Factual; Drug Design; HIV Reverse Transcriptase; Models, Molecular; Molecular Conformation; Molecular Structure; Protein Binding; Quantitative Structure-Activity Relationship; Reverse Transcriptase Inhibitors; Statistics as Topic; Thermodynamics | 2005 |
QSAR for non-nucleoside inhibitors of HIV-1 reverse transcriptase.
Topics: Alkynes; Benzoxazines; Combinatorial Chemistry Techniques; Cyclopropanes; HIV Reverse Transcriptase; HIV-1; Molecular Structure; Mutation; Oxazines; Quantitative Structure-Activity Relationship; Quinazolines; Quinazolinones; Reverse Transcriptase Inhibitors | 2006 |